EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study

Yukino Katakura, Masashi Shimoda, Mana Ohnishi, Takashi Kusano, Kazunori Dan, Hayato Isobe, Ryo Wamata, Yuichiro Iwamoto, Yoshiro Fushimi, Junpei Sanada, Atsushi Obata, Tomohiko Kimura und 5 weitere

Nutrition, Metabolism and Cardiovascular Diseases · 2023

DOI: 10.1016/j.numecd.2023.02.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2023. Verfasst von Yukino Katakura und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. Hauptthemen laut MEDLINE: Hypertriglyceridemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kawasaki Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertriglyceridemiaHumansRetrospective StudiesPPAR alphaBenzoxazolesTriglyceridesButyrates

Stichwörter der Autor:innen

HypertriglyceridemiaNonalcoholic fatty liver diseasePemafibrateSelective peroxisome proliferator-activated receptor-α modulatorSmall dense low-density lipoproteinTriglyceride-rich lipoproteins

Substanzen

PPAR alphaBenzoxazolesTriglycerides(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acidButyrates

Autor:innen und Institutionen

  • Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan.
  • Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, 701-0192, Japan. Electronic address: masashi-s@med.kawasaki-m.ac.jp.

Förderung

  • Kawasaki Medical School

Zitieren

APA

Katakura, Y., Shimoda, M., Ohnishi, M., Kusano, T., Dan, K., Isobe, H., Wamata, R., Iwamoto, Y., Fushimi, Y., Sanada, J., Obata, A., Kimura, T., Tatsumi, F., Nakanishi, S., Mune, T., Kaku, K., & Kaneto, H. (2023). Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2023.02.011

Vancouver

Katakura Y, Shimoda M, Ohnishi M, Kusano T, Dan K, Isobe H, et al. Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study. Nutrition, Metabolism and Cardiovascular Diseases. 2023. doi:10.1016/j.numecd.2023.02.011

BibTeX
@article{Katakura2023,
  author = {Katakura, Yukino and Shimoda, Masashi and Ohnishi, Mana and Kusano, Takashi and Dan, Kazunori and Isobe, Hayato and Wamata, Ryo and Iwamoto, Yuichiro and Fushimi, Yoshiro and Sanada, Junpei and Obata, Atsushi and Kimura, Tomohiko and Tatsumi, Fuminori and Nakanishi, Shuhei and Mune, Tomoatsu and Kaku, Kohei and Kaneto, Hideaki},
  title = {Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2023},
  doi = {10.1016/j.numecd.2023.02.011}
}
Kostenlos starten →